Shock wave therapy relieves plantar fasciitis pain

NEW YORK (Reuters Health) - Patients with a common and painful heel condition called plantar fasciitis benefit from a new type of shock wave therapy in which energy is delivered across a broader area of the foot, German researchers report.

The treatment, called radial extracorporeal shock wave therapy (ESWT), “can be strongly recommended for patients with therapy-resistant plantar painful heel syndrome,” Dr. Ludger Gerdesmeyer of the Mare Clinic in Kiel-Kronshagen and colleagues write. “Especially in the cases of failed nonsurgical treatment, ESWT represents an excellent alternative to surgery because anesthesia is not required and long recovery times are avoided.”

Plantar fasciitis is an inflammation of the tissue supporting the arch of the foot. About 10 percent of patients may need surgical treatment, which can require an extended recovery period, Gerdesmeyer and his team note in their report.

ESWT is increasingly being used as an alternative to surgery for plantar fasciitis, Gerdesmeyer and his team note, but clinical trials comparing it with placebo have yielded contradictory results. Standard ESWT delivers focused shock waves to the most tender point on the patient’s foot, they explain, while ESWT covers a larger area and does not penetrate as deeply into tissue.

To investigate the effectiveness of the new treatment, the researchers randomly assigned 245 patients with chronic plantar fasciitis to undergo three treatments 2 weeks apart with ESWT or a sham treatment with a device that did not transmit shock waves.

After 12 weeks, patients who underwent the real treatment had a 72.1 percent reduction in their heel pain scores, while the reduction for the placebo group averaged 44.7 percent.

One year after treatment, pain scores were 84.8 percent lower than at the study’s outset for the treatment group, while the placebo group’s pain scores dropped by 43.2 percent. Patients assigned to rESWT also showed significantly greater improvement in their quality of life and ability to function in daily life compared with those who received the sham treatment.

“Thus, there is evidence for benefit of patients with painful heel by ESWT treatment not only through reduced pain but also generally improved well being,” Gerdesmeyer and colleagues conclude.

The maker of the radial ESWT devise, Switzerland-based Electro Medical Systems, funded the study but was not involved in collecting or analyzing the data, according to the researchers. They also disclosed a potential conflict of interest of one or more of the study authors.

SOURCE: American Journal of Sports Medicine, November 2008.


Related Posts:

By Julie Steenhuysen CHICAGO (Reuters) - A simple office procedure helped relieve stubborn heel pain, offering a new way to treat plantar fasciitis, the most common cause of heel pain, Italian researchers said on Monday. Some 95 percent of patients who got the treatment, which involves injecting an ultrasound-guided needle into the area, had no symptoms after

Full Post: Treatment helps ease stubborn heel pain: study

NEW YORK (Reuters Health) - A type of mind-body treatment popular in Europe known as Mensendieck somatocognitive therapy can help ease chronic pelvic pain in women, with effects lasting several months after treatment ends, Norwegian researchers report. Women with chronic pain often experience “somatic dissociation,” or a loss of awareness of their own bodies, Dr. Gro

Full Post: Mind-body therapy eases chronic pelvic pain

NEW YORK (Reuters Health) - People with severe asthma who are allergic to fungal organisms benefit substantially from treatment with the anti-fungal drug itraconazole, new research shows. To check out this strategy, a trial was conducted in the UK involving patients who needed high doses of steroids to control their asthma and who were sensitive to

Full Post: Antifungal treatment helps some asthma patients

By David Douglas NEW YORK (Reuters Health) - In children who continue to wet the bed despite standard treatment with desmopressin, adding the bladder-control drug tolterodine (Detrol) to therapy leads to a significant decrease in the risk of bedwetting, Missouri-based researchers have found. Desmopressin, lead researcher Dr. Paul F. Austin told Reuters Health, is the most frequently

Full Post: Drug combo may help curb bedwetting

NEW YORK (Reuters Health) - Traditional acupuncture and non-penetrating sham acupuncture both appear to help relieve pelvic pain in pregnant women, Swedish researchers report. However, contrary to expectation, neither acupuncture approaches is more effective than the other. It’s estimated that 30 percent of pregnant women suffer from pelvic pain while pregnant. Pelvic pain is one of

Full Post: Acupuncture may relieve pelvic pain in pregnancy

Site Navigation

Most Read